JTC Employer Solutions Trustee’s Takeda Pharmaceutical TAK Stock Holding History

JTC Employer Solutions Trustee’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-971	Closed	-$14K	–	346
2024 Q1	$14K	Hold	971	–	–	﹤0.01%	304
2023 Q4	$14K	Hold	971	–	–	﹤0.01%	303
2023 Q3	$15K	Hold	971	–	–	﹤0.01%	309
2023 Q2	$15K	Hold	971	–	–	﹤0.01%	314
2023 Q1	$16K	Hold	971	–	–	﹤0.01%	316
2022 Q4	$15K	Hold	971	–	–	﹤0.01%	333
2022 Q3	$13K	Hold	971	–	–	﹤0.01%	274
2022 Q2	$14K	Hold	971	–	–	﹤0.01%	254
2022 Q1	$14K	Hold	971	–	–	﹤0.01%	266
2021 Q4	$13K	Hold	971	–	–	﹤0.01%	269
2021 Q3	$16K	Hold	971	–	–	﹤0.01%	267
2021 Q2	$16K	Buy	+971	New	+$16.5K	﹤0.01%	261

Other funds holding TAK

GAM

Groupama Asset Management Paris, France $7.93B AUM 57.28% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

JTC Employer Solutions Trustee's TAK Position: Q2 2024 in Review

JTC Employer Solutions Trustee sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 971 shares — an estimated $14K sold.

JTC Employer Solutions Trustee first reported a position in TAK in Q2 2021 and held it in 12 quarters. The position peaked at $16K in Q1 2023. 285 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

JTC Employer Solutions Trustee reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
JTC Employer Solutions Trustee sold 971 Takeda Pharmaceutical shares in Q2 2024, an estimated $14K.
JTC Employer Solutions Trustee first reported a position in Takeda Pharmaceutical in Q2 2021 and held it in 12 quarters.
JTC Employer Solutions Trustee's Takeda Pharmaceutical position peaked at $16K in Q1 2023.
285 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2024, filed 16 Jul 2024.